


Alaxia breaks new ground with lead compound ALX-009 as virucidal agent

ANS Biotech appoints Dr. Philippe Genne to board of directors

Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc.

Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology

Fab’entech launches COVID-19 immunotherapy program

Tollys receives over €1.5 million deep tech financing from Bpifrance

BCI Pharma appoints Didier Malherbe as chairman of board of directors

Advanced BioDesign and Luxembourg Institute of Health (LIH) join forces to explore new therapeutic strategies for overcoming tumor resistance
